Do Sandoz’ Q2 Results Indicate US Bottom Is In Sight?

Novartis Unit Raises Annual Guidance As Q2 ‘Outweighs Expectations’

 
• By Dean Rudge
  
Dollars (incamerastock/Alamy Stock Photo)
Is the bottom "increasingly likely?" • Source: Shutterstock (incamerastock / Alamy Stock Phot/Alamy Stock Photo)
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business